| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6247005 | Transplantation Proceedings | 2016 | 4 Pages |
Abstract
Tacrolimus dose was significant higher in functional CYP3A5 expressers. Only 42.8% of such expressers had tacrolimus trough levels â¥7 ng/mL at 1 month after transplantation despite dose adjustments. Long-term follow up is needed to address the consequences of early post-transplantation bioavailability differences due to CYP3A5 genotype.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
A.C. Alvarez-ElÃas, P. GarcÃa-Roca, L. Velásquez-Jones, S. Valverde, G. Varela-Fascinetto, M. Medeiros,